研究单位:[1]Beijing TianTanHospital, China Capital Medical University[2]Beijing Neurosurgical Institute[3]Beijing Children's Hospital[4]Beijing Shijitan Hospital, Capital Medical University[5]Xuanwu Hospital, Beijing[6]Peking University Third Hospital
The purpose of this study:(1) Development of a new risk classification model for childhood medulloblastoma. (2) Evaluation and improvement of existing individualized treatment protocols.